Skip to main content
. 2020 Nov 11;10:19590. doi: 10.1038/s41598-020-76558-5

Table 1.

Baseline characteristics of the volunteers at each of the visits.

Visit 1 Visit 2 Visit 3
Weight (kg) 65.9 ± 10.1 66.1 ± 9.7 66.3 ± 9.8
Height (m) 1.69 ± 0.09 1.69 ± 0.09 1.69 ± 0.09
BMI (kg/m2) 23.13 ± 2.96 23.19 ± 2.90 23.28 ± 3.08
Waist (cm) 75.2 ± 8.4 75.5 ± 7.3 75.2 ± 7.7
Hip (cm) 98.1 ± 6.9 98.2 ± 6.6 98.1 ± 6.8
Waist to hip ratio 0.77 ± 0.07 0.77 ± 0.06 0.77 ± 0.06
Systolic BP (mmHg) 116 ± 8 114 ± 7 115 ± 9
Diastolic BP (mmHg) 71 ± 6 72 ± 6 71 ± 6
tCys (μmol/L) 260 ± 27 261 ± 25 260 ± 26
tHCys (μmol/L) 9.9 ± 4.7 9.3 ± 3.9 9.5 ± 4.0
tCysGly (μmol/L) 32.8 ± 6.4 29.5 ± 5.3 30.4 ± 6.6
tGSH (μmol/L) 8.9 ± 2.6 7.4 ± 1.4 7.4 ± 1.8
Glucose (mmol/L) 4.7 ± 0.3 4.8 ± 0.4 4.8 ± 0.4
Insulin (pmol/L) 52.1 ± 14.1 55.0 ± 16.4 58.0 ± 18.4
Uric acid (mmol/L) 0.26 ± 0.06 0.26 ± 0.05 0.26 ± 0.08

Characterization of the participants that completed the full three visits (n = 38), with data presented for each visit as the mean ± standard deviation (SD). Values were not significantly different between visits (p > 0.05; parametric ANOVA with repeated measures). Data in fasting plasma are comparable to published values (μmol/L): Cys: 219 ± 1462; 256 ± 1763; 321 ± 5064; for HCys: 9.5 ± 0.462; 9.9 ± 2.465 ; 14.1 ± 4.964; for CysGly: 24.4 ± 4.564; 39.7 ± 4.962; for GSH: 2–2066; 5.69 ± 1.3364; 9.07 ± 1.5562. t = total. BP, blood pressure.